Iodine deficiency ! - falling intakes - goitregens - competition bromine and fluorine

[R.B.]

Here is another paper looking at the Wolff-Chaikoff effect, here again after ingestion / injection of a large amount of iodine there is a large fall in uptake, and temporary drop in T3 and T4, (T3 then recovers, and T4 increases) a metabolic adjustment but hardly a thyroid 'shutdown' as often described, in the in the normal sense of the word 'shutdown'.


http://endo.endojournals.org/content...expansion.html

http://endo.endojournals.org/content/140/8/3404.long

[R.B.]

Hashimoto's

An interesting pair of posts on Paul Jaminet's site by a Hashimoto's patient which is well referenced and highlights the importance of selenium, possible benefits at least in some of iodine supplementation, and the fundamental importance of a balanced intake of both selenium and iodine to thyroid function.

http://perfecthealthdiet.com/2011/05...iditis-part-i/

http://perfecthealthdiet.com/2011/05...iditis-part-2/

[R.B.]

Hasimoto's

Multifactoral - As ever it is important to keep in mind that most medical conditions are likely to be mutli-factoral, and have multiple associations with increased risks of other medical conditons Eg Hashimotos patients may be at increased risk of Pagets bone disease, http://europepmc.org/articles/PMC188...00365-0047.pdf which common bone conditions is linked with low vitamin D, begging the question is there maybe a link between low vitamin D and Hashimoto's . . .


The association between severity of vitamin D deficiency and Hashimoto's thyroiditis.
Bozkurt NC, Karbek B, Ucan B, Sahin M, Cakal E, Ozbek M, Delibasi T.
Author information
Abstract
OBJECTIVE:

The relation between vitamin D and autoimmune disorders has long been investigated regarding the important roles of this hormone in immune regulation. We evaluated 25-hydroxyvitamin D (25OHD) status in subjects with Hashimoto's thyroiditis (HT) and healthy controls.
METHODS:

Group-1 included 180 euthyroid patients (123 females/57 males) with HT who were on a stable dose of L-thyroxine (LT). A total of 180 sex-, age-, and body mass index (BMI)-matched euthyroid subjects with newly diagnosed HT were considered as Group-2, and 180 healthy volunteers were enrolled as controls (Group-3). All 540 subjects underwent thyroid ultrasound and were evaluated for serum 25OHD, anti-thyroid peroxidase (anti-TPO), and anti-thyroglobulin (anti-TG) levels.
RESULTS:

Group-1 had the lowest 25OHD levels (11.4 ± 5.2 ng/mL) compared to newly diagnosed HT subjects (Group-2) (13.1 ± 5.9 ng/mL, P = .002) and to control subjects (15.4 ± 6.8 ng/mL, P<.001). Serum 25OHD levels directly correlated with thyroid volume (r = 0.145, P<.001) and inversely correlated with anti-TPO (r = -0.361, P<.001) and anti-TG levels (r = -0.335, P<.001). We determined that 48.3% of Group-1, 35% of Group-2, and 20.5% of controls had severe 25OHD deficiency (<10 ng/mL). Female chronic HT patients had the lowest serum 25OHD levels (10.3 ± 4.58 ng/mL), and male control subjects had the highest (19.3 ± 5.9 ng/mL, P<.001).
CONCLUSIONS:

We demonstrated that serum 25OHD levels of HT patients were significantly lower than controls, and 25OHD deficiency severity correlated with duration of HT, thyroid volume, and antibody levels. These findings may suggest a potential role of 25OHD in development of HT and/or its progression to hypothyroidism.